A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: A single-center study of first cadaveric kidneys to nonsensitized recipients

Transplantation

Volumn 66, Issue 4, 1998, Pages 523-528

  Reisæter, Anna V ^a   Leivestad, TorbjØrn ^a   Vartdal, Frode ^a   Spurkland, Anne ^a   Fauchald, Per ^a   Brekke, Inge B ^a   Thorsby, Erik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DNA; HLA DR ANTIGEN; METHYLPREDNISOLONE; OKT 3; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CADAVER KIDNEY; CHILD; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HLA-DR ANTIGENS; HUMANS; IMMUNOCOMPETENCE; INFANT; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0032572744     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808270-00018     Document Type: Article

References (41)

1. Eurotransplant International Foundation Annual Report 1995. Cohen B, Persijn G, De Meester J, eds. Leiden: Eurotransplant Foundation.
2. Harper AM, Baker AS. The UNOS OPTN waiting list: 1988-1995. In: Cecka JM, Terasaki PI, eds. Clinical transplants 1995. Los Angeles: UCLA Tissue Typing Laboratory, 1996.
3. Terasaki PI, Cho Y, Takemoto S, Cecka M, Gjertson D. Twenty-year follow-up on the effect of HLA matching on kidney transplant survival and prediction of future twenty-year survival. Transplant Proc 1996; 28: 1144.
4. Opelz G, Wujciak T. Cadaveric kidneys should be allocated according to the HLA match. Transplant Proc 1995; 27: 93.
5. Connolly JK, Dyer PA, Matin S, Parrott NR, Pearson RC, Johnson RWG. Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation. Transplantation 1996; 61: 709.
6. Pirsch JD, Ploeg RJ, Gange S, et al. Determinants of graft survival after renal transplantation. Transplantation 1996; 61: 1581.
7. Cicciarelli J, Iwaki Y, Mendez R, et al. Effects of cold ischemia time on cadaver renal allografts. Tranplant Proc 1993; 25: 1543.
8. Belitsky P, MacDonald AS, Lawen J, et al. Kidney transplantation: the Halifax experience. In: Cecka JM, Terasaki PI, eds. Clinical transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory, 1997.
9. Alexander JW, Bennett LE, Breen TJ. Effect of donor age on outcome of kidney transplantation. Transplantation 1994; 57: 871.
10. Chertow GM, Milford EL, Mackenzie HS, Brenner BM. Antigen-independent determinants of cadaveric kidney transplant failure. JAMA 1996; 276: 1732.
11. Takemoto S, Terasaki PI, Cecka M, Cho YW, Gjertson DW. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. N Engl J Med 1992; 327: 834.
12. Thorogood J, Schreuder GMTh, Persijn GG, van Rood JJ. Organ sharing based on HLA matching saves dialysis years and patient lives. Transplant Proc 1993; 25: 3049.
13. Martin S, Connolly J, Parrott NR, Pearson RC, Johnson RWG, Dyer PA. HLA-DR mismatching in cadaveric kidney transplantation minimized through organ sharing for 1000 consecutive transplants. Transplant Proc 1993; 25: 3047.
14. Leivestad T, Sødal G, Bratlie A, et al. Role of HLA matching in cadaveric renal transplantation: influence of improved serological HLA-DR typing. Transplant Proc 1993; 25: 220.
15. Leivestad T, Spurkland A, Knutsen I, et al. Genomic HLA-DRB1 matching further improves clinical course after renal transplantation. Transplant Proc 1995; 27: 678.
16. Midtvedt K, Tafjord AB, Hartmann A, et al. Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection. Transplantation 1996; 62: 38.
17. Vartdal F, Gaudernack G, Funderud S, et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation: a fast and reliable technique. Tissue Antigens 1986; 28: 301.
18. Spurkland A, Ingvarsson G, Falk ES, Knutsen I, Sollid LM, Thorsby E. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (α1*0501, β1*02) or the HLA-DQ (α1*03, β1*0302) heterodimers. Tissue Antigens 1997; 49: 29.
19. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsjui K, Aizawa M, Sasazuki T, eds. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford Science Publications, 1992: 397.
20. Verduyn W, Doxiadis IIN, Anholts J, et al. Biotinylated DRB sequence-specific oligonucleotides: comparison to serologic HLA-DR typing of organ donors in Eurotransplant. Hum Immunol 1993; 37: 59.
21. Ting A, Morris PJ. Matching for B-cell antigens of the HLA-DR series in cadaver renal transplantation. Lancet 1978; 1: 575.
22. Persijn GG, Gabb BW, van Leeuwen A, Nagtegaal A, Hoogeboom J, van Rood JJ. Matching for HLA antigens A, B and DR loci in renal transplantation by Eurotransplant. Lancet 1978; 1: 1278.
23. Albrechtsen D, Flatmark A, Jervell J, Halvorsen S, Solheim BG, Thorsby E. Significance of D/DR matching in renal transplantation. Lancet 1978; 2: 1126.
24. Lundgren G, Albrechtsen D, Flatmark A, et al. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation: a changing picture with cyclosporin. Lancet 1986; 2: 66.
25. Kapsner T, Schneeberger H, Land W. How valid are risk factors for chronic transplant failure in renal transplant patients found in the literature with regard to our patients: results of a multivariate analysis. Transplant Proc 1995; 27: 878.
26. Jakobsen BK, Ryder LP, Ladefoged J, et al. Strong impact of HLA-DR-matching on graft survival in 413 consecutive cadaver kidney transplants performed in Copenhagen over an eight-year period. Transplant Proc 1995; 27: 3452.
27. Candinas D, Schlumpf R, Röthlin MA, Binswanger U, Largiader F. Thirty-two years of renal transplantation in Zurich. In: Cecka JM, Terasaki PI, eds. Clinical transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory, 1997.
28. Kerman RH, Kimball PM, Lindholm A, et al. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival. Transplantation 1993; 56: 1242.
29. Matas AJ, Frey DJ, Gillingham KJ, et al. The impact of HLA matching on graft survival and on sensitization after failed renal transplant: evidence that failure of poorly matched renal transplants does not result in increased sensitization. Transplantation 1990; 50: 599.
30. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. Transplantation 1995; 59: 962.
31. Giral M, Taddei C, Nguyen JM, et al. Single center analysis of 486 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy. In: Cecka JM, Terasaki PI, eds. Clinical Transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory, 1997.
32. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141.
33. McLean AG, Hughes D, Welsh KI, et al. Patterns of graft infiltration and cytokine gene expression during the first 10 days of kidney transplantation. Transplantation 1997; 63: 374.
34. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
35. Flechner SM, Modlin CS, Serrano DP, et al. Determinants of chronic renal allograft rejection in cyclosporine-treated recipients. Transplantation 1996; 62: 1235.
36. Massy ZA, Guijarro C, Wiederkehr MR, Ma JZ, Kasiske BL. Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int 1996; 49: 518.
37. Thorogood J, Persijn GG, Schreuder GMTh, et al. The effect of HLA matching on kidney graft survival in separate posttrans-plantation intervals. Transplantation 1990; 50: 146.
38. Thorogood J, van Houwelingen JC, van Rood JJ, Zantvoort FA, Schreuder GMTh, Persijn GG. Factors contributing to long-term kidney graft survival in Eurotransplant. Transplantation 1992; 54: 152.
39. Zantvoort FA, D'Amaro J, Persijn GG, et al. The impact of HLA-A matching on long-term survival of renal allografts. Transplantation 1996; 61: 841.
40. Mytilineos J, Lempert M, Middleton D, et al. HLA class I DNA typing of 215 "HLA-A, -B, -DR zero mismatched" kidney transplants. Tissue Antigens 1997; 50: 355.
41. Thorsby E. Transplantation immunology: a brief update. Transplant Proc 1997; 29: 3129.